Prosecution Insights
Last updated: October 25, 2026

Children’S Hospital Of Chongqing Medical University

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Children'S Hospital Of Chongqing Medical University has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, WELLS, LAUREN QUINLAN, who is also the busiest examiner for the portfolio with 1 pending office action. The prosecution is currently limited to 1 distinct art unit.

The concentration of the entire active portfolio under 1 distinct examiner suggests a very narrow technical focus for the company's current filings. This allows practitioners to tailor their arguments specifically to the preferences and examination style of WELLS, LAUREN QUINLAN. The lack of multiple active cases simplifies the coordination required to maintain consistency across the portfolio.

Operating within a single art unit provides a stable environment for patent prosecution. The company can expect the application of a uniform set of examination standards and prior art interpretations. This focused approach reduces the complexity of managing the company's intellectual property interests at the patent office.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
ARMATO JR, DENNIS IGNATIUS 1 42.9% +80.0%
RAMADAN, OMAR 1 25.4% +56.5%

Hard Cases (2)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18721917 METHOD AND KIT FOR IMMUNOTYPING OF T LYMPHOCYTE DEVELOPMENT SUBGROUPS RAMADAN, OMAR 176d overdue
18916729 APPLICATION OF PREVOTELLA COPRI IN PREVENTING AND TREATING ATTENTION-DEFICIT-HYPERACTIVITY DISORDER ARMATO JR, DENNIS IGNATIUS —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18721917 METHOD AND KIT FOR IMMUNOTYPING OF T LYMPHOCYTE DEVELOPMENT SUBGROUPS RAMADAN, OMAR 176d overdue
18916729 APPLICATION OF PREVOTELLA COPRI IN PREVENTING AND TREATING ATTENTION-DEFICIT-HYPERACTIVITY DISORDER ARMATO JR, DENNIS IGNATIUS —

Top Art Units

Art UnitApps
1651 1
1678 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18916729 APPLICATION OF PREVOTELLA COPRI IN PREVENTING AND TREATING ATTENTION-DEFICIT-HYPERACTIVITY DISORDER ARMATO JR, DENNIS IGNATIUS 1651 §103§112 Non-Final OA — Pending Oct 16, 2024
18721917 METHOD AND KIT FOR IMMUNOTYPING OF T LYMPHOCYTE DEVELOPMENT SUBGROUPS RAMADAN, OMAR 1678 §103 Non-Final OA 176d overdue Pending Jun 20, 2024

Managing Children’S Hospital Of Chongqing Medical University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Children’S Hospital Of Chongqing Medical University have?

Children’S Hospital Of Chongqing Medical University has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Children’S Hospital Of Chongqing Medical University applications?

Dennis Ignatius Armato Jr. has the most, with 1 of Children’S Hospital Of Chongqing Medical University's pending office actions.

What technology area are Children’S Hospital Of Chongqing Medical University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month